B3 Solutions today announced it has been awarded a prime position on the Acquisition Domain of the Omnibus Program Engineering and Technical Support contract. The five-year IDIQ contract expands the company’s presence at the DOD’s Joint Program Executive Office for Chemical and Biological Defense. B3 Solutions will support JPEO-CBD in the developing and fielding of chemical and biological defense material.
“We look forward to providing the critical expertise required to help develop chemical and biological defense solutions,” said Bud Almas, B3 Solutions CEO. “Nothing is more important than keeping our armed forces and civilians out of harm’s way.”
If all options are exercised, B3 and 22 other awardees in the acquisition domain will have the potential to receive the full value amount of the IDIQ contract.
